drugset / Trial / NCT05723549
A Study to Evaluate the PK, Safety and Tolerability of HCP1803.
RandomizedParallel-groupOpen-labelTreatment
Summary
A randomized, open-label, single-dose parallel study to evaluate the pharmacokinetics, safety and tolerability of HCP1803 in healthy male volunteers.
Timeline
- Start
- 2023-02-02
- Primary completion
- 2023-03-20
- Completion
- 2023-03-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HCP1803-3 | Unknown | — | — |
| Comparator | HCP1904-1 | Unknown | — | — |
| Comparator | RLD2002 | Unknown | — | — |
Indications
No indication recorded.